All data are based on the daily closing price as of July 18, 2024
n

NeoPharm

092730.KQ
19.31 USD
-0.14
-0.72%

Overview

Last close
19.31 usd
Market cap
154.28M usd
52 week high
24.19 usd
52 week low
12.68 usd
Target price
26.04 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.8645
Price/Book Value
1.1314
Enterprise Value
50.72M usd
EV/Revenue
0.7221
EV/EBITDA
2.2571

Key financials

Revenue TTM
62.79M usd
Gross Profit TTM
45.12M usd
EBITDA TTM
16.78M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
136.18M usd
Net debt
N/A usd

About

NeoPharm CO., LTD. manufactures and sells skin care products in South Korea. The company offers Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand; products for sensitive, dry, oily, or trouble-prone skin under the ZEROID brand; body moisturizers under the Derma-B brand; and sport care products for athletes under the MISSION ATHELETCARE brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.
  • Symbol
    092730.KQ
  • Exchange
    KQ
  • Isin
    KR7092730001
  • Country
    South Korea
  • Sector
    Consumer Non-Cyclicals
  • Industry
    Personal & Household Products & Services
  • CEO
    Byeong-Deog Park
  • Headquarter
    Daejeon
  • Web site
    https://www.neopharm.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top